Botanical species · safety record
Hydrastis canadensis
The EFSA Compendium of Botanicals holds 25 constituent measurements and 8 adverse-effect records for Hydrastis canadensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Hydrastis canadensis L.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 665 licensed products naming Hydrastis canadensis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Hydrastine7
- Berberine6
- Alkaloids4
- Canadine4
- Palmatine2
- Hydrastinine1
- Isoquinoline alkaloids1
Plant parts
- Roots and other underground parts27
- Unspecified6
Preparations
- Solvent extraction17
Effect types
- Hepatotoxicity8
Target tissues
- Liver8
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Alkaloids | Roots and other underground parts | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Alkaloids | Roots and other underground parts | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Alkaloids | Roots and other underground parts | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Alkaloids | Roots and other underground parts | — | 6.86 Percent | Unspecified | Resolve DOI |
| Berberine | Roots and other underground parts | — | 3.89 Percent | Unspecified | Resolve DOI |
| Berberine | Roots and other underground parts | Solvent extraction | 1.9 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Berberine | Roots and other underground parts | Solvent extraction | 2.52 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Berberine | Roots and other underground parts | — | 3.89 Percent | Unspecified | Resolve DOI |
| Canadine | Roots and other underground parts | — | 0.17 Percent | Unspecified | Resolve DOI |
| Canadine | Roots and other underground parts | — | 0.17 Percent | Unspecified | Resolve DOI |
| Canadine | Roots and other underground parts | Solvent extraction | 0.06 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Canadine | Roots and other underground parts | Solvent extraction | 0.04 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Hydrastine | Roots and other underground parts | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Hydrastine | Roots and other underground parts | — | 2.8 Percent | Unspecified | Resolve DOI |
| Hydrastine | Roots and other underground parts | — | 2.8 Percent | Unspecified | Resolve DOI |
| Hydrastine | Roots and other underground parts | Solvent extraction | 1.3 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Hydrastine | Roots and other underground parts | Solvent extraction | 1.38 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Hydrastinine | Roots and other underground parts | Solvent extraction | < 0.06 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Palmatine | Roots and other underground parts | Solvent extraction | 0.1 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Palmatine | Roots and other underground parts | Solvent extraction | 0.22 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Berberine | Roots and other underground parts | Solvent extraction | ≤ 3.45 Percent | HPLC-UV | No resolvable identifier |
| Berberine | Roots and other underground parts | Solvent extraction | ≥ 2.79 Percent | HPLC-UV | No resolvable identifier |
| Hydrastine | Roots and other underground parts | Solvent extraction | ≤ 4.05 Percent | HPLC-UV | No resolvable identifier |
| Hydrastine | Roots and other underground parts | Solvent extraction | ≥ 2.24 Percent | HPLC-UV | No resolvable identifier |
| Isoquinoline alkaloids | Roots and other underground parts | — | — | — | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Hepatotoxicity | Liver | Unspecified | — | House mouse (as animal) | Subchronic | Resolve DOI |
| Hepatotoxicity | Liver | Unspecified | — | Rat (as animal) | Subchronic | Resolve DOI |
| Hepatotoxicity | Liver | Roots and other underground parts | — | Rat (as animal) | Case report | Resolve DOI |
| Hepatotoxicity | Liver | Roots and other underground parts | — | House mouse (as animal) | Case report | Resolve DOI |
| Hepatotoxicity | Liver | Unspecified | — | House mouse (as animal) | Subchronic | No resolvable identifier |
| Hepatotoxicity | Liver | Unspecified | — | House mouse (as animal) | Subchronic | No resolvable identifier |
| Hepatotoxicity | Liver | Unspecified | — | Rat (as animal) | Subchronic | No resolvable identifier |
| Hepatotoxicity | Liver | Unspecified | — | Rat (as animal) | Subchronic | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Dunnick, June K., Singh, Bhanu., Nyska, Abraham., Peckham, John., Kissling, Grace E., Sanders, J. Michael. Investigating the Potential for Toxicity from Long-Term Use of the Herbal Products, Goldenseal and Milk Thistle . Toxicologic pathology, 2011, vol. 39, no. 2, p. 398-409. DOI
- Dunnick, June K., Nyska, Abraham. The Toxicity and Pathology of Selected Dietary Herbal Medicines. Toxicologic pathology, 2013, vol. 41, no. 2, p. 374-386. DOI
- Toxicology and carcinogenesis studies of goldenseal root powder (Hydrastis Canadensis) in F344/N rats and B6C3F1 mice (feed studies). . National toxicology program technical report series, 2010, no. 562, p. 1-188.
- Brown, Paula N., Roman, Mark C. Determination of hydrastine and berberine in goldenseal raw materials, extracts, and dietary supplements by high-performance liquid chromatography with UV: Collaborative study . Journal of aoac international, 2008, vol. 91, no. 4, p. 694-701.
- Weber, HA., Zart, MK., Ferguson, SL., Greaves, JG., Clark, AP., Harris, RK., Overstreet, D., Smith, C. Separation and quantitation of isoquinoline alkaloids occurring in goldenseal . Journal of liquid chromatography & related technologies, 2001, vol. 24, no. 1, p. 87-95. DOI
- Inbaraj, J. J., Kukielczak, B. M., Bilski, P., He, Y. -Y., Sik, R. H., Chignell, C. F. Photochemistry and photocytotoxicity of alkaloids from goldenseal (Hydrastis canadensis L.). 2. Palmatine, hydrastine, canadine, and hydrastinine . Chemical research in toxicology, 2006, vol. 19, no. 6, p. 739-744. DOI
- Avula, Bharathi., Wang, Yan-Hong., Khan, Ikhlas A. Quantitative Determination of Alkaloids from Roots of Hydrastis canadensis L. and Dietary Supplements Using Ultra-Performance Liquid Chromatography with UV Detection . Journal of aoac international, 2012, vol. 95, no. 5, p. 1398-1405. DOI
- Messana, Irene., La Bua, Roberto., Galeffi, Corrado. The alkaloids of Hydrastis canadensis L. (Ranunculaceae). Two new alkaloids: hydrastidine and isohydrastidine. Gazzetta chimica italiana, 1980, vol. 110(9-10), p. 539-43.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.